Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Total 13F shares
-
8,692,790
-
Share change
-
+2,197,263
-
Total reported value
-
$61,930,042
-
Price per share
-
$7.12
-
Number of holders
-
67
-
Value change
-
+$15,659,235
-
Number of buys
-
36
-
Number of sells
-
22
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q3 2025
As of 30 Sep 2025,
Journey Medical Corp - Common Stock (DERM) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,692,790 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, WASATCH ADVISORS LP, Opaleye Management Inc., BlackRock, Inc., VANGUARD GROUP INC, Summit Financial, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and Pale Fire Capital SE.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.